From the Globe and Mail:
Conventional wisdom about the treatment of Crohn's disease is being turned on its head by a new study.
Traditionally, patients diagnosed with the devastating inflammatory bowel disease are treated with a "step-up" approach, a series of drugs given sequentially as their health deteriorates.
First, they get corticosteroids to control symptoms like abdominal pain and bloody diarrhea. They are then prescribed a powerful immune-suppressing drug, which prepares them for a third medication, an antibody that curbs the inflammation at the root of the disease.
But a group of European and Canadian researchers decided to see what would happen if they treated newly diagnosed Crohn's patients immediately with a combination of an immune-suppressing drug, azathioprine, and an antibody, infliximab, simultaneously. Patients were only treated with steroids if they had symptoms.
In the study, published in today's edition of The Lancet, this "step-down" approach proved to be markedly more effective. ...more
Showing posts with label azathioprine. Show all posts
Showing posts with label azathioprine. Show all posts
Friday, March 07, 2008
Reverse treatment aids Crohn's sufferers
Labels:
azathioprine,
Crohn's Disease,
infliximab,
research
Subscribe to:
Posts (Atom)